Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
A case of acute combined central and peripheral demyelination.
KIR4.1 Antibodies as Biomarkers in Multiple Sclerosis.
The complex immunology of multiple sclerosis.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.
Aquatic training in MS: neurotherapeutic impact upon quality of life.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Can HPV immunisation cause ADEM? Two case reports and literature review.
Quality of life and employment in persons with multiple sclerosis.
Antibody index test may aid PML diagnosis on natalizumab
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
[Current description of multiple sclerosis].
Automatic segmentation and volumetry of multiple sclerosis brain lesions from MR images.
Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
A PheWAS approach in studying HLA-DRB1*1501.
The Immune Pathogenesis of Multiple Sclerosis.
Assessing the safety of biologic agents in patients with rheumatoid arthritis.

Pages